[HTML][HTML] Bibliometric study on the utilization of sorafenib in hepatocellular carcinoma
W Meng, Y Luo, L Zhao, Y Zhang, J Liu… - Frontiers in …, 2024 - pmc.ncbi.nlm.nih.gov
Background Although the number of studies on sorafenib for hepatocellular carcinoma
(HCC) is increasing during the past two decades, no detailed scientometric examination of …
(HCC) is increasing during the past two decades, no detailed scientometric examination of …